Transmedics Group Inc
TMDX
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.99B
Close$
$86.08
1.1% downside
Current Fair Value
1.1% downsideOvervalued by 1.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.99 Billion |
|---|---|
| Enterprise Value | $3.38 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.6 |
| Beta | 1.88 |
| Outstanding Shares | 34,579,980 |
Return
| Return on Equity | 29.28% |
|---|---|
| Return on Assets | 10.36% |
| Return on Invested Capital | 6.69% |
Valuation & Multiples
| P/E Ratio | 19.55 |
|---|---|
| PEG | -33.75 |
| Price to Sales | 4.58 |
| Price to Book Ratio | 6.21 |
| Enterprise Value to Revenue | 5.06 |
| Enterprise Value to EBIT | 37.02 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 1.68 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.50
Average shareholder expectationRevenue Estimate
$184.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.27
Average shareholder expectationRevenue Estimate
$176.94 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1869▲ 33.65% |
|---|---|
| Total Calls | 1,507,000▲ 162.96% |
| Total Puts | 1,788,700▲ 267.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 101.62%▼ 4.44% |
|---|---|
| Total Invested | $2.34B▼ 35.55% |
| Investors Holding | 405▼ 30.00% |
ESG Score
No data